Q3 2019 Holdings
Filed 2019-11-14 | 60 holdings | $237.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $142.2M | 1,767,628 | 59.9% |
| Apyx Med Corp(APYX) | COM | 03837C106 | $22.8M | 3,370,279 | 9.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $17.4M | 809,623 | 7.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $17.1M | 846,121 | 7.2% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $13.5M | 745,045 | 5.7% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $8.5M | 5,562,967 | 3.6% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $7.3M | 990,463 | 3.1% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $3.6M | 31,516 | 1.5% |
| CareDx Inc(CDNA) | COM | 14167L103 | $3.5M | 154,951 | 1.5% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $192.5K | 16,587,491 | 0.1% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $123.5K | 3,651,361 | 0.1% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $89.1K | 6,202,425 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $79.4K | 1,565,307 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $69.4K | 3,355,466 | 0.0% |
| Milestone Pharmaceuticals In(MIST) | COM | 59935V107 | $63.8K | 3,521,856 | 0.0% |
| Zimmer Biomet Hldgs Inc(ZBH) | COM | 98956P102 | $55.3K | 403,000 | 0.0% |
| Masimo Corp(MASI) | COM | 574795100 | $55.2K | 371,155 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $54.6K | 724,311 | 0.0% |
| Achillion Pharmaceuticals In(ACHNEUR) | COM | 00448Q201 | $49.9K | 13,864,383 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $46.2K | 592,776 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $44.3K | 2,449,478 | 0.0% |
| Axonics Modulation Tech Inc(AXNX*) | COM | 05465P101 | $41.3K | 1,534,605 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $40.1K | 2,645,476 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $38.6K | 2,039,681 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $37.8K | 725,025 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $34.2K | 6,281,003 | 0.0% |
| Translate Bio Inc | COM | 89374L104 | $31.2K | 3,148,628 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $26.9K | 4,178,156 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $23.8K | 9,213,191 | 0.0% |
| ProQR Thrapeutics N V | SHS EURO | N71542109 | $21.3K | 3,700,833 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $18.3K | 111,232 | 0.0% |
| La Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $17.7K | 2,016,269 | 0.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $15.1K | 116,858 | 0.0% |
| MiMedx Group Inc(MDXG) | COM | 602496101 | $14.5K | 2,964,000 | 0.0% |
| DermTech Inc(DMTKQ) | COM | 24984K105 | $12.5K | 2,386,871 | 0.0% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $12.0K | 503,266 | 0.0% |
| Quidel Corp | COM | 74838J101 | $10.8K | 176,495 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $10.4K | 291,168 | 0.0% |
| Quotient Ltd | SHS | G73268107 | $10.0K | 1,281,143 | 0.0% |
| Fluidigm Corp Del(LAB) | COM | 34385P108 | $9.8K | 2,109,500 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $9.4K | 287,470 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $9.2K | 762,283 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $8.8K | 339,892 | 0.0% |
| Silk Road Medical Inc | COM | 82710M100 | $8.0K | 244,716 | 0.0% |
| Exagen Inc(XGN) | COM | 30068X103 | $7.9K | 511,633 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $7.7K | 270,948 | 0.0% |
| Brainsway Ltd(BWAY) | SPONSORED ADS | 10501L106 | $7.6K | 834,687 | 0.0% |
| Chardan Healthcare Acquisiti | UNIT 12/13/2023 | 15957A207 | $7.2K | 600,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $5.7K | 144,909 | 0.0% |
| Inmode Ltd(INMD) | SHS | M5425M103 | $5.4K | 250,000 | 0.0% |